Aging Well with HIV: A Multidimensional Care Approach

This two-module activity addresses the current state of HIV in the US and healthy aging considerations for persons living with HIV (PLWH). Also included are brief vignettes of actual patient interviews. Their perspectives will provide insight into the daily challenges and quality of life issues that can occur while living with HIV.

In module 1, our experts discuss the graying of the HIV pandemic, understanding geriatric syndromes and comprehensive geriatric assessment, creating an age-friendly health system, advanced care considerations and addressing barriers to care. Module 2 addresses common drug-drug interactions, promoting adherence, ART optimization, and polypharmacy.

The growing number of PLWH over age 50 requires research to develop a more comprehensive understanding of the health consequences of HIV in older individuals. The intent of this CME program is to help clinicians improve the health of older PLWH.

Target Audience

Infectious disease specialists, geriatricians, primary care and internal medicine physicians, pharmacists, NP/PAs, and nurses

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Evaluate age-related considerations for treating HIV to promote better health in the aging population.
  • Compare and contrast new and emerging ARTs for efficacy, safety, and adherence potential.
  • Assess and connect the adverse effects of polypharmacy on the health of HIV-infected patients.
  • Outline factors associated with decreased retention in HIV medical care and employ proven strategies to promote re-engagement in care.

 

This program is supported by an educational grant from Gilead Sciences, Inc and Merck. 

Course summary
Available credit: 
  • 2.00 ACPE Pharmacy
  • 2.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 2.00 ANCC
Course opens: 
03/15/2022
Course expires: 
03/15/2023
Rating: 
0

ACCME: 

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NCPD:

Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Contact Hours 2, of which 1.25 are eligible for pharmacology credit (if applicable)

ACPE: 

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This is an application-based educational activity. Pharmacists will receive 2.0 contact hours (0.20 CEUS) for the educational activity. No partial credit is available. Initial Release Date: August 1, 2021. Planned Expiration Date: March 15, 2023.

Universal Activity Number (UAN): 0060-9999-22-11-H02-P

Available Credit

  • 2.00 ACPE Pharmacy
  • 2.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 2.00 ANCC
Please login or register to take this course.